Brexit is impacting employers in the pharmaceuticals sector more than in most parts of the economy as the industry relies heavily on expertise from overseas. Our latest blog sets out some recommended steps to take now.

We look at why now is a good time for firms to take stock of their preparations for the Investment Firm Prudential Regime.

While we may be able to regain many aspects of pre-pandemic life over the coming months, the NHS is now facing another extensive challenge - to restore and recover its planned care services.

Regulators and the public want more action on climate change and social value. How should the home affairs and justice sector respond? We set out six ways they can act now.